---
title: "Persistent Borrelia burgdorferi Antigen in CD14⁺CD16⁺ Monocytes Linked to Immune Remodeling in PTL"
id: "medrxiv-0-persistent-borrelia-burgdorferi-protein-antigen-in-cd16-monocytes-is-associated"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-0-persistent-borrelia-burgdorferi-protein-antigen-in-cd16-monocytes-is-associated"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.24.26363601v1?rss=1"
published_at: "2026-10-01T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Persistent Borrelia burgdorferi Antigen in CD14⁺CD16⁺ Monocytes Linked to Immune Remodeling in PTL
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-0-persistent-borrelia-burgdorferi-protein-antigen-in-cd16-monocytes-is-associated
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.24.26363601v1?rss=1)
- **Published At:** 2026-10-01T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study examined whether **Borrelia burgdorferi** protein antigen persists in long-lived monocyte subsets of people with post-treatment Lyme disease syndrome (PTLDS) and whether such persistence associates with immune dysregulation. - CD14⁺CD16⁺ monocytes from 10 PTLDS patients were analyzed by mass spectrometry; plasma cytokines from the same 10 were profiled versus 50 healthy donors; PBMCs from 6 patients (3 antigen-positive, 3 antigen-negative) underwent RT-qPCR and bulk RNA-seq with immune-compartment profiling. - Borrelia proteins FlaB and OspC were detected in CD14⁺CD16⁺ monocytes months to years after antibiotic treatment, while Borrelia burgdorferi RNA transcripts were not detected in these samples. - Plasma **IFN-γ** concentrations exceeded the healthy donor median in all 10 PTLDS participants. - Antigen-positive samples displayed an inflammatory transcriptional signature with increased expression of TNFSF14/LIGHT, GSDMD, GBP5, and KCNJ2, consistent with antigen-associated inflammation. - At the compartment level, antigen-positive cases showed a **monocyte-skewed myeloid reconfiguration**, elevated neutrophil-related features, and selective alterations in T-cell states. - Authors interpret results as supporting a model where residual bacterial protein antigens drive sustained immune remodeling in post-infectious syndromes rather than ongoing replicating infection. - The study is a preprint and not peer-reviewed. Competing interests include employees of HealthBio Inc. and use of the Immunogram platform by Caucell Inc. RNA-seq data are available at GEO accession GSE348165.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=4UNEXGQ5TNQF6Tp0sGxP2ti7MfV0VNsB3asi1nr7zfU-1790880284.1171014-1.2.1.1-XrvKzGiBYy78fzkcYDk.VrinShT1D1bGxayKELiFQFWPIobCU7nTJdSgcDUxDNn3) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.09.24.26363601v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Persistent Borrelia burgdorferi protein antigen in CD16⁺ monocytes is associated with monocyte-skewed immune dysregulation in post-treatment Lyme disease syndrome (PTLDS) Bruce K Patterson, Edgar B Francisco, Nicolas Castaño, Kwat Medetgul-Ernar, Christopher Beaty, Kaeden Beaty, Patricia A Felder, Ram Yogendra doi: https://doi.org/10.64898/2026.09.24.26363601 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Bruce K Patterson 1 HealthBio Inc.; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Bruce%2BK%2BPatterson%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Patterson%20BK&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ABruce%2BK%2BPatterson%2B) * For correspondence: brucep@healthbio.com Edgar B Francisco 1 HealthBio Inc.; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Edgar%2BB%2BFrancisco%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Francisco%20EB&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AEdgar%2BB%2BFrancisco%2B) Nicolas Castaño 2 Caucell Inc.; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Nicolas%2BCasta%C3%B1o%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Casta%C3%B1o%20N&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ANicolas%2BCasta%25C3%25B1o%2B) Kwat Medetgul-Ernar 3 Stanford University * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Kwat%2BMedetgul-Ernar%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Medetgul-Ernar%20K&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AKwat%2BMedetgul-Ernar%2B) Christopher Beaty 1 HealthBio Inc.; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Christopher%2BBeaty%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Beaty%20C&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AChristopher%2BBeaty%2B) Kaeden Beaty 1 HealthBio Inc.; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Kaeden%2BBeaty%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Beaty%20K&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AKaeden%2BBeaty%2B) Patricia A Felder 1 HealthBio Inc.; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Patricia%2BA%2BFelder%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Felder%20PA&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3APatricia%2BA%2BFelder%2B) Ram Yogendra 1 HealthBio Inc.; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ram%2BYogendra%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Yogendra%20R&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ARam%2BYogendra%2B) * [Abstract](https://www.medrxiv.org/content/10.64898/2026.09.24.26363601v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1311718/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.09.24.26363601v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1311718/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.09.24.26363601v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1311718/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.09.24.26363601v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1311718/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.09.24.26363601v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1311718/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Post-treatment Lyme disease syndrome (PTLDS) is characterized by persistent symptoms after antibiotic therapy for Borrelia burgdorferi infection. The mechanisms underlying these symptoms remain incompletely understood and have been attributed to ongoing low-level infection, autoimmunity, or immune dysregulation driven by residual bacterial antigens. We investigated whether Borrelia burgdorferi protein antigen persists in long-lived monocyte subsets in PTLDS patients and is associated with broader immune dysregulation. CD14⁺CD16⁺ monocytes from 10 patients with PTLDS were analyzed by mass spectrometry; plasma from all 10 was profiled on a 14-plex cytokine panel against 50 healthy donors; PBMCs from 6 patients (3 antigen-positive and 3 antigen-negative) underwent RT-qPCR and bulk RNA-seq with immune-compartment profiling. FlaB and OspC were detected in CD14⁺CD16⁺ monocytes months to years after treatment, whereas Borrelia burgdorferi transcript was not detected. Plasma IFN-γ exceeded the healthy donor median in all 10 participants. Antigen-positive samples showed an antigen-associated inflammatory transcriptional profile, including increased TNFSF14/LIGHT, GSDMD, GBP5, and KCNJ2 expression, together with a compartment-level pattern of monocyte-skewed myeloid reconfiguration, higher neutrophil-related features, and selective T-cell-state changes. These findings link residual Borrelia burgdorferi protein in CD14⁺CD16⁺ monocytes to monocyte-skewed immune remodeling in PTLDS, paralleling observations in long COVID and supporting a model in which post-infectious syndromes are sustained by antigen-fueled immune remodeling rather than ongoing infection. ### Competing Interest Statement Bruce K. Patterson, Christopher Beaty, Kaeden Beaty, Patricia A. Felder, Edgar B. Francisco and Ram Yogendra are employees of HealthBio Inc. Nicolas Castaño and Kwat Medetgul-Ernar are affiliated with Caucell Inc., which developed the Immunogram platform used in this study. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Ethics IRB of the Chronic COVID Treatment Center (protocol CCTC-008) gave ethical approval for this work. All participants provided written informed consent prior to participation. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability The data supporting the findings of this study are available within this article and in the supplemental material. The RNA sequencing data discussed have been deposited in NCBI's Gene Expression Omnibus (Patterson et al., 2026) and are accessible through GEO Series accession number GSE348165. ## Funder Information Declared Stanford University Medical Scientist Training Program, T32-GM007365 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY 4.0 International license](http://creativecommons.org/licenses/by/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.09.24.26363601v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.09.29.26364323v1 "Glycaemic outcomes of three months of continuous glucose monitoring in children, adolescents and young adults with type 1 diabetes at a Kenyan tertiary hospital: a single-arm prospective study.")[Next ](https://www.medrxiv.org/content/10.64898/2026.09.30.26363196v1 "Benchmarking modular skills and fixed orchestration across six large language models in a meta-analysis task") Posted October 01, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.09.24.26363601v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/10/01/2026.09.24.26363601.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.09.24.26363601v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/10/01/2026.09.24.26363601.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Persistent Borrelia burgdorferi protein antigen in CD16⁺ monocytes is associated with monocyte-skewed immune dysregulation in post-treatment Lyme disease syndrome (PTLDS) Bruce K Patterson, Edgar B Francisco, Nicolas Castaño, Kwat Medetgul-Ernar, Christopher Beaty, Kaeden Beaty, Patricia A Felder, Ram Yogendra medRxiv 2026.09.24.26363601; doi: https://doi.org/10.64898/2026.09.24.26363601 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.24.26363601v1%26text%3DPersistent%2520Borrelia%2520burgdorferi%2520protein%2520antigen%2520in%2520CD16%25E2%2581%25BA%2520monocytes%2520is%2520associated%2520with%2520monocyte-skewed%2520immune%2520dysregulation%2520in%2520post-treatment%2520Lyme%2520disease%2520syndrome%2520%2528PTLDS%2529 "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.24.26363601v1%26t%3DPersistent%2520Borrelia%2520burgdorferi%2520protein%2520antigen%2520in%2520CD16%25E2%2581%25BA%2520monocytes%2520is%2520associated%2520with%2520monocyte-skewed%2520immune%2520dysregulation%2520in%2520post-treatment%2520Lyme%2520disease%2520syndrome%2520%2528PTLDS%2529 "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.24.26363601v1%26title%3DPersistent%2520Borrelia%2520burgdorferi%2520protein%2520antigen%2520in%2520CD16%25E2%2581%25BA%2520monocytes%2520is%2520associated%2520with%2520monocyte-skewed%2520immune%2520dysregulation%2520in%2520post-treatment%2520Lyme%2520disease%2520syndrome%2520%2528PTLDS%2529%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.24.26363601v1%26title%3DPersistent%2520Borrelia%2520burgdorferi%2520protein%2520antigen%2520in%2520CD16%25E2%2581%25BA%2520monocytes%2520is%2520associated%2520with%2520monocyte-skewed%2520immune%2520dysregulation%2520in%2520post-treatment%2520Lyme%2520disease%2520syndrome%2520%2528PTLDS%2529 "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.09.24.26363601) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.09.24.26363601v1&count=horizontal&via=&text=Persistent%20Borrelia%20burgdorferi%20protein%20antigen%20in%20CD16%E2%81%BA%20monocytes%20is%20associated%20with%20monocyte-skewed%20immune%20dysregulation%20in%20post-treatment%20Lyme%20disease%20syndrome%20%28PTLDS%29&counturl=www.medrxiv.org/content/10.64898/2026.09.24.26363601v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (622) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (910) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (339) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4869) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (483) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (420) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (657) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1639) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (16035) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (34) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1214) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7114) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (735) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1071) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5102) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1445) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1787) * [Hematology](https://www.medrxiv.org/collection/hematology) (589) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1353) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16344) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1182) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (675) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (156) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (728) * [Neurology](https://www.medrxiv.org/collection/neurology) (7358) * [Nursing](https://www.medrxiv.org/collection/nursing) (370) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1097) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1255) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1009) * [Oncology](https://www.medrxiv.org/collection/oncology) (3647) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1064) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (399) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (459) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (481) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (141) * [Pathology](https://www.medrxiv.org/collection/pathology) (710) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1818) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (740) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (772) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (5962) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9816) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2454) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (146
## Related Clinical Research

- [Soluble urokinase plasminogen activator receptor (suPAR) across the kidney–cardiometabolic continu](https://medichelpline.com/clinical-feed/frontiers-in-immunology-17-soluble-urokinase-plasminogen-activator-receptor-across-the-kidney.md)
- [Spatial risk modeling forecasts US measles re-emergence and guides targeted vaccination](https://medichelpline.com/clinical-feed/medrxiv-8-epidemiologic-shifts-predict-spatial-patterns-of-measles-re-emergence-in-the.md)
- [Beyond conventional biomarkers: editorial on novel biomarkers and combinatorial approaches for imm](https://medichelpline.com/clinical-feed/frontiers-in-immunology-16-editorial-beyond-conventional-biomarkers-unlocking-immunotherapy-response.md)
- [Insulin-binding B cells emerge in early-stage type 1 diabetes without somatic hypermutation or aut](https://medichelpline.com/clinical-feed/biorxiv-3-insulin-binding-b-cells-can-arise-in-early-stage-type-1-diabetes-individuals-in.md)
- [Key Developments in Endocrinology for October 16, 2026](https://medichelpline.com/clinical-feed/endocrine-news-0-pharma-friday-october-16-2026.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.